Atlas Trials

Immune Checkpoint Inhibition in Combination With Radiation Therapy in Pancreatic Cancer or Biliary Tract Cancer Patients

Clinical trial NCT02866383 · COMPLETED

Trial details

NCT number
NCT02866383
Sponsor
Herlev Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Pancreatic CancerMetastatic Biliary Tract Cancer
Start date
2016-11-01
Primary completion
2022-01-05
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.